Enoxaparin shortage — AU supply status & alternatives

Enoxaparin

ATC B01AB05 · Low molecular weight heparin

🇦🇺 AUST R 375491 · Juno Pharmaceuticals Pty Ltd

In shortage · Australia

ClexaneLovenoxEnoxalowEXARANE FORTE enoxaparin sodiumEnoxaparin Sodium Injection, USP

In declared shortage · 🇦🇺 Australia & also short in🇺🇸 US🇨🇦 CA🇪🇸 ES🇧🇪 BE🌐 MY

Critical shortage

Product discontinued / no longer available on the Australian market.

Reading today’s signals…

🇦🇺 AUAEMPA$23.34DPMQ A$63.04details →

• Can I substitute?

No pathway on record

prescriber decision required

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Enoxaparin
Brand names	Clexane, Lovenox, Enoxalow, EXARANE FORTE enoxaparin sodium, Enoxaparin Sodium Injection, USP
ATC level 5	B01AB05
ATC level 4	B01AB
Drug class	Low molecular weight heparin
Therapeutic category	Cardiovascular
Strength	20mg/0.2ml · 40mg/0.4ml · 60mg/0.6ml · 80mg/0.8ml · 100mg/1ml
Dosage form	solution for injection
Route of administration	subcutaneous · intravenous
Controlled substance	No
Marketing-authorisation holders	Juno Pharmaceuticals Pty Ltd, Sanofi-Aventis Australia Pty Ltd
Registrations on file	16
Patient information leaflet (PIL)	Not on file
Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 PBS · July 2026

🇦🇺 AU

● Official price on file

Ex-manufacturer

A$23.34

AEMP

Dispensed (DPMQ)

A$63.04

incl. fees

Pack

enoxaparin sodium 20 mg/0.2 mL injection, 10 x 0.2 mL syringes

solution for injection

Source: PBSEffective July 2026 · AUD

Other markets

🇺🇸 US

US$7.37

Acquisition

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

How long have past shortages lasted? from 5 resolved events

◷

0–3 months

Historical pattern from resolved shortage records — not a prediction of this event.

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

13 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Low concentration risk

Yantai Dongcheng Biochemicals CO LTDEmcure Pharmaceuticals LTDApitoria Pharma Private LTDDongying Tiandong Pharmaceutical CO LTDCelsus Laboratories INCHangzhou Jiuyuan Gene Engineering CO LTD+7 more

Manufacturing countries: China, India · Source: FDA List of Drug Master Files

Shortage status by regulator official notices

🇦🇺

Australia

TGA · 1h ago

Critical

🇺🇸

United States

FDA MedWatch · 1mo ago

Critical

🇨🇦

Canada

HC · 1h ago

High

🌐

NPRA · 1d ago

Medium

🇧🇪

FAMHP · 1mo ago

Medium

🇪🇸

Spain

AEMPS · 1mo ago

Medium

Verified timeline regulator events

🇦🇺 3 June 2026

high reported

🇦🇺 3 June 2026

high reported

🇧🇪 25 May 2026

medium reported

🇦🇺 14 May 2026

high reported

🇦🇺 14 May 2026

high reported

🇪🇸 22 Apr 2026

Shortage resolved

Sources official regulators

🇨🇦

verified 1h ago

verify ↗

🇦🇺

TGA

verified 1h ago

verify ↗

🌐

NPRA

verified 1d ago

verify ↗

🇧🇪

FAMHP

verified 1mo ago

verify ↗

🇪🇸

AEMPS

verified 1mo ago

verify ↗

🇺🇸

FDA MedWatch

verified 1mo ago

verify ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders16 registrations · 2 MA holders

Product	Strength	Form	Market	MA holder	Status
EXARANE enoxaparin sodium	100mg	—	🇦🇺 AU	Juno Pharmaceuticals Pty Ltd	Active
EXARANE enoxaparin sodium	40mg	—	🇦🇺 AU	Juno Pharmaceuticals Pty Ltd	Active
EXARANE FORTE enoxaparin sodium	120mg	—	🇦🇺 AU	Juno Pharmaceuticals Pty Ltd	Active
EXARANE enoxaparin sodium	80mg	—	🇦🇺 AU	Juno Pharmaceuticals Pty Ltd	Active
EXARANE enoxaparin sodium	20mg	—	🇦🇺 AU	Juno Pharmaceuticals Pty Ltd	Active
EXARANE FORTE enoxaparin sodium	150mg	—	🇦🇺 AU	Juno Pharmaceuticals Pty Ltd	Active
EXARANE enoxaparin sodium	60mg	—	🇦🇺 AU	Juno Pharmaceuticals Pty Ltd	Active
CLEXANE enoxaparin sodium	40mg	—	🇦🇺 AU	Sanofi-Aventis Australia Pty Ltd	Active
CLEXANE enoxaparin sodium	20mg	—	🇦🇺 AU	Sanofi-Aventis Australia Pty Ltd	Active
CLEXANE enoxaparin sodium	60mg	—	🇦🇺 AU	Sanofi-Aventis Australia Pty Ltd	Active
CLEXANE enoxaparin sodium	80mg	—	🇦🇺 AU	Sanofi-Aventis Australia Pty Ltd	Active
CLEXANE enoxaparin sodium	100mg	—	🇦🇺 AU	Sanofi-Aventis Australia Pty Ltd	Active
CLEXANE FORTE enoxaparin sodium	120mg	—	🇦🇺 AU	Sanofi-Aventis Australia Pty Ltd	Active
CLEXANE FORTE enoxaparin sodium	150mg	—	🇦🇺 AU	Sanofi-Aventis Australia Pty Ltd	Active
ENOXAPO enoxaparin sodium	100 mg	—	🇦🇺 AU	—	Active

+1 more registration on file

Mederti Drug Report

Generated 3 July 2026 · Australia market · 6 regulatory sources

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.